当前位置: X-MOL 学术Crit. Care Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield.
Critical Care Medicine ( IF 8.8 ) Pub Date : 2022-01-10 , DOI: 10.1097/ccm.0000000000005439
Bertrand Mathon 1, 2 , Malory Favreau 3 , Vincent Degos 3 , Aymeric Amelot 1 , Alexandre Le Joncour 4 , Nicolas Weiss 5, 6 , Benjamin Rohaut 2, 5 , Loïc Le Guennec 5 , Anne-Laure Boch 1 , Alexandre Carpentier 1 , Franck Bielle 2, 7 , Karima Mokhtari 7 , Ahmed Idbaih 2, 8 , Mehdi Touat 2, 8 , Alain Combes 9 , Alexandre Demoule 10, 11 , Eimad Shotar 12 , Vincent Navarro 2, 13 , Mathieu Raux 14 , Sophie Demeret 5 , Marc Pineton De Chambrun 9, 15, 16 ,
Affiliation  

Brain biopsy is a useful surgical procedure in the management of patients with suspected neoplastic lesions. Its role in neurologic diseases of unknown etiology remains controversial, especially in ICU patients. This study was undertaken to determine the feasibility, safety, and the diagnostic yield of brain biopsy in critically ill patients with neurologic diseases of unknown etiology. We also aimed to compare these endpoints to those of non-ICU patients who underwent a brain biopsy in the same clinical context.

中文翻译:

重症患者病因不明的神经系统疾病的脑活检:可行性、安全性和诊断率。

脑活检是治疗疑似肿瘤病变患者的一种有用的外科手术。它在病因不明的神经系统疾病中的作用仍然存在争议,特别是在 ICU 患者中。本研究旨在确定对患有不明原因神经系统疾病的危重患者进行脑活检的可行性、安全性和诊断率。我们还旨在将这些终点与在相同临床背景下接受脑活检的非 ICU 患者的终点进行比较。
更新日期:2022-01-10
down
wechat
bug